355 results on '"Kransdorf E"'
Search Results
2. Monotherapy in Heart Transplantation Proves to Be Safe While Followed by T-Cell Immune Function Testing
3. Clinical Course of Obese Advanced Heart Failure Patients Who Underwent Bariatric Surgery
4. Settling the Issue: Does Neupogen Increase the Risk of Rejection After Heart Transplant?
5. Is Treatment of Asymptomatic Isolated C1 Q Positive Donor Specific Antibody After Heart Transplant Efficacious?
6. Concomitant Cell-Free DNA and Donor Specific Antibodies: Do They Predict Outcomes After Heart Transplant?
7. Does Racial Difference Affect Outcome After Heart-Kidney Transplantation?
8. Real World Use of the Cardiac Allograft Vasculopathy (CAV) Score to Monitor for CAV After Heart Transplant
9. Randomized Trial to Evaluate the Safety and Efficacy of the Sherpa Pak Device versus Cold Storage of Donor Hearts in Transplantation: A Pilot Study
10. The Impact of Pre-Heart Transplant Body Mass Index on Long-Term Clinical Outcomes According to the Age Distribution
11. Role of KCCQ Overall Summary Score in Predicting Mortality in Heart Failure Patients
12. Importance of transplant era on post-heart transplant predictive models: A UNOS cohort analysis
13. Prevalence of concealed arrhythmogenic substrate for sudden cardiac arrest in the general population
14. (1063) Clinical Prediction Model for Advanced Fibrosis in Heart Transplant Candidates
15. (1051) The Validation of Cardiac Rehabilitation after Heart Transplantation from Anonymized Patient-Reported Outcomes
16. (437) Extreme HLA Homozygosity Contributing to Extreme HLA Sensitization
17. (105) Clinical Outcomes of Heart Transplantation in Desensitized Durable Mechanical Circulatory Support Patients
18. (103) Homozygosity at Multiple HLA Loci Increases the Risk of Sensitization but Decreases the Risk of Rejection
19. Sex Differences in Desensitization for Patients Awaiting Heart Transplantation: Is There a Difference?
20. NP Telehealth Blood Pressure Management in Heart Transplant Patients - A Single Center Experience
21. Do Women Truly Have Less Than Optimal Outcome Post-Heart Transplantation Compared to Men
22. Is Delayed Graft Function Worse in Simultaneous Heart-Kidney Transplant vs Kidney Transplant Alone?
23. The Effects of Hypomagnesemia Post Heart Transplantation
24. Is Donor Smoking Truly a Risk Factor for the Development of Cardiac Allograft Vasculopathy?
25. Are Calcineurin Inhibitor-Free Protocols Safe and Effective in the Long-Term After Heart Transplant?
26. Anti-Thymocyte Globulin Protects Against Ischemia Reperfusion Injury in the Immediate Post Heart Transplant Period
27. When is Significant Left Ventricular Hypertrophy Acceptable for Donor Heart Selection
28. Cardiac Amyloidosis with a Dilated Phenotype: Participant or Bystander?
29. Are Markedly Oversized Donor Hearts Associated with Poor Outcome After Heart Transplantation?
30. Donor Alkalemia is Associated with Severe Primary Graft Dysfunction
31. Outcomes Following Heart Transplant for Patients with Cardiac Amyloidosis
32. Treatment and Outcome of AL Amyloid After Heart Transplantation: Is It Viable?
33. (299) - Randomized Trial to Evaluate the Safety and Efficacy of the Sherpa Pak Device versus Cold Storage of Donor Hearts in Transplantation: A Pilot Study
34. (454) - The Impact of Pre-Heart Transplant Body Mass Index on Long-Term Clinical Outcomes According to the Age Distribution
35. (404) - Rationale, Design and Patient Characteristics from The DevelopmEnt of Non-Invasive Cell-Free DNA to Supplant INvasivE Biopsy in Heart Transplantation (DEFINE-HT) Study
36. (1108) - Settling the Issue: Does Neupogen Increase the Risk of Rejection After Heart Transplant?
37. (1107) - Monotherapy in Heart Transplantation Proves to Be Safe While Followed by T-Cell Immune Function Testing
38. (1083) - Clinical Course of Obese Advanced Heart Failure Patients Who Underwent Bariatric Surgery
39. (749) - Is Treatment of Asymptomatic Isolated C1 Q Positive Donor Specific Antibody After Heart Transplant Efficacious?
40. (747) - Does the Number of Donor Specific Antibodies Crossed at the Time of Heart Transplant Impact Post-Transplant Outcome?
41. (743) - Does Racial Difference Affect Outcome After Heart-Kidney Transplantation?
42. (383) - Real World Use of the Cardiac Allograft Vasculopathy (CAV) Score to Monitor for CAV After Heart Transplant
43. (166) - Role of KCCQ Overall Summary Score in Predicting Mortality in Heart Failure Patients
44. (72) - Concomitant Cell-Free DNA and Donor Specific Antibodies: Do They Predict Outcomes After Heart Transplant?
45. Development and validation of an individual predictive model for risk of biopsy-proven antibody-mediated rejection after heart transplantation
46. Development and validation of specific post-transplant risk scores according to the circulatory support status at transplant: A UNOS cohort analysis
47. The Effects of Donor-Specific Antibody Characteristics on Cardiac Allograft Vasculopathy
48. Is a Switch to Cyclosporine from Tacrolimus a Risk in Heart Transplant Recipients?
49. Does Crossing Historical DSA in Patients Undergoing Heart Transplantation Have Any Impact on Post-Transplant Outcomes?
50. Prophylaxis for Chagas Disease Reactivation: Is it Necessary?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.